Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Mar;32(3):851–853. doi: 10.1128/jcm.32.3.851-853.1994

Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.

G J Doellgast 1, M X Triscott 1, G A Beard 1, J D Bottoms 1
PMCID: PMC263141  PMID: 8195408

Abstract

The solution-phase complex assay for toxins A, B, and E from Clostridium botulinum (Elcatech, Inc., Winston-Salem, N.C.) was modified to measure antibody. The addition of unlabeled polyclonal antibodies to a mixture consisting of toxin with chicken antibody and RVV-XA-labeled horse antibody reduces the sensitivity of detection of neurotoxin. This reduction in sensitivity can be used as a measure of the specific antibody titer.

Full text

PDF
851

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Doellgast G. J., Beard G. A., Bottoms J. D., Cheng T., Roh B. H., Roman M. G., Hall P. A., Triscott M. X. Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies. J Clin Microbiol. 1994 Jan;32(1):105–111. doi: 10.1128/jcm.32.1.105-111.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doellgast G. J., Triscott M. X., Beard G. A., Bottoms J. D., Cheng T., Roh B. H., Roman M. G., Hall P. A., Brown J. E. Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol. 1993 Sep;31(9):2402–2409. doi: 10.1128/jcm.31.9.2402-2409.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hatheway C. H., Snyder J. D., Seals J. E., Edell T. A., Lewis G. E., Jr Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis. 1984 Sep;150(3):407–412. doi: 10.1093/infdis/150.3.407. [DOI] [PubMed] [Google Scholar]
  4. Siegel L. S. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid. J Clin Microbiol. 1989 Aug;27(8):1906–1908. doi: 10.1128/jcm.27.8.1906-1908.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Siegel L. S. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J Clin Microbiol. 1988 Nov;26(11):2351–2356. doi: 10.1128/jcm.26.11.2351-2356.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES